home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Inducible Regulation Of Runx2-Stimulated Osteogenesis

  May, 24 2006 7:59
your information resource in human molecular genetics
Ex vivo gene therapy is a promising approach to orthopedic regenerative medicine, but the unregulated production of osteoinductive molecules has also resulted in abnormal bone formation and tumorigenesis. To address these limitations, Gersbach et al. (Gene Therapy, Vol. 13, pp. 873-882) describe a retroviral system to deliver the Runx2 osteoblastic transcription factor. Their results present a novel system for regulating osteoblastic differentiation of a clinically relevant autologous cell source, which is significant to developing controlled and effective orthopedic gene therapy strategies and studying the regulation of osteoblastic differentiation.


Dr AJ García, Petit Institute for Bioengineering and Bioscience, 315 Ferst Drive, Room 2314, Atlanta, GA 30332-0363, USA. E-mail: andres.garcia@me.gatech.edu

Abstract available online.

(C) Gene Therapy.

Posted by: Tressie Dalaya.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.